Dr. Richard Stephen Grodman, MD

Dr. Grodman practices at Richmond University Medical Center in Staten Island, New York, part of Richmond University Medical Center.

Dr. Grodman's NPI, 1578502365, was assigned on June 6, 2006. Dr. Grodman graduated from State University of New York Downstate Medical Center in 1973. Dr. Grodman holds New York license 123591.

Dr. Grodman's primary practice is Richmond University Medical Center, at 355 Bard Avenue, Staten Island, NY 10310 in Richmond County. The practice phone is (718) 354-5047.

Dr. Grodman's primary practice is Richmond University Medical Center in Staten Island, New York, part of Richmond University Medical Center. The medical group on file is Amboy Medical Practice PC.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grodman practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Grodman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Grodman is licensed in New York.

CMS data shows 663 Medicare services from Dr. Grodman across 4 procedure codes in 2024, for 563 Medicare patients. Medicare paid $36,413 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 563 Medicare patients who saw Dr. Grodman in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grodman's median patient age at 66, with 46% women.

In 2019, Dr. Grodman wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $398 in total drug cost. In 2017, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Grodman for performance year 2024, reported through an alternative payment model (APM). Dr. Grodman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 338 general payments to Dr. Grodman from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,522.

Dr. Grodman graduated from State University of New York Downstate Medical Center in 1973.